In a meta-analysis mainly comprising the adults with T2DM, the pen devices were superior to syringe vials in terms of mean HbA1c change, hypoglycemic episodes, adherence, and persistence to insulin, although no difference was observed in the number of patients achieving glycemic target (HbA1c < 7%). This evidence concerns the gene INS and type 2 diabetes mellitus.